(Q36787569)

16 August 2017

1 reference

title

The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications (English)

1 reference

16 August 2017

6

Ann Marie Schmidt

1 reference

16 August 2017

Shi Fang Yan

1

1 reference

16 August 2017

Gaetano R Barile

2

1 reference

16 August 2017

Vivette D'Agati

3

1 reference

16 August 2017

Shi Du Yan

4

1 reference

16 August 2017

Ravichandran Ramasamy

5

1 reference

16 August 2017

language of work or name

1 reference

1 April 2007

1 reference

16 August 2017

Current diabetes report

1 reference

16 August 2017

7

1 reference

16 August 2017

2

1 reference

16 August 2017

146-153

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-007-0024-4

16 August 2017

0 references

cites work

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0024-4

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0024-4

Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0024-4

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0024-4

Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-007-0024-4

Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease

21 January 2018

1 reference

12 December 2020

N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.

1 reference

12 December 2020

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

12 December 2020

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

1 reference

12 December 2020

RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB

1 reference

12 December 2020

Upregulation of RAGE and its ligands in proliferative retinal disease

1 reference

12 December 2020

Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells

1 reference

12 December 2020

Impaired peripheral nerve regeneration in diabetes mellitus

1 reference

12 December 2020

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

12 December 2020

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications

1 reference

12 December 2020

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

12 December 2020

Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice

1 reference

12 December 2020

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

12 December 2020

Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice

1 reference

12 December 2020

Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells

1 reference

12 December 2020

RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin

1 reference

12 December 2020

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

12 December 2020

The potential role of amyloid beta in the pathogenesis of age-related macular degeneration

1 reference

12 December 2020

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

12 December 2020

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

1 reference

12 December 2020

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

1 reference

12 December 2020

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

1 reference

12 December 2020

RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.

1 reference

12 December 2020

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

1 reference

12 December 2020

Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity

1 reference

12 December 2020

RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways

1 reference

12 December 2020

Antagonism of RAGE suppresses peripheral nerve regeneration

1 reference

12 December 2020

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes

1 reference

12 December 2020

S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)

1 reference

12 December 2020

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

12 December 2020

Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation

1 reference

12 December 2020

The RAGE axis in early diabetic retinopathy

1 reference

12 December 2020

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

1 reference

12 December 2020

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

12 December 2020

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

1 reference

12 December 2020

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

1 reference

12 December 2020

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

1 reference

12 December 2020

Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes

1 reference

12 December 2020

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice

1 reference

12 December 2020

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

12 December 2020

Central role of RAGE-dependent neointimal expansion in arterial restenosis

1 reference

12 December 2020

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

12 December 2020

Advanced glycation end products modulate the maturation and function of peripheral blood dendritic cells

1 reference

12 December 2020

10.1007/S11892-007-0024-4

Identifiers

DOI

1 reference

16 August 2017

1 reference